Promising drug shrinks kidney cysts.
ADPKD, the prevalent form of polycystic kidney disease, causes kidney enlargement, often leading to function loss.
Source: newswise.com
Page 2 - Long Professor News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Long Professor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Long Professor Today - Breaking & Trending Today
Building Community to Advance Metabolic Science
Mitochondria and intermediary metabolism are central to health and disease, yet many of us learn a simplified version of this complex science. To develop
Source: yale.edu
Diabetes Dialogue: PROTECT Data and Teplizumab in Newly Diagnosed T1D
In this episode, hosts discuss data from the PROTECT trial, which examined the effects of teplizumab on beta-cell function in patients with newly diagnosed type 1 diabetes.
Source: hcplive.com
For Type 1 Diabetes, Teplizumab (Tzield) Preserves Beta Cell Function and Shows Significant Other Benefits
The preservation of insulin-producing beta cells is just one of the benefits of teplizumab, also known as Tzield, a phase 3 trial shows.
Source: yale.edu
Press Release: TZIELD® Phase 3 data presented at ISPAD shows potential to slow the progression of Stage 3 type 1 diabetes in newly diagnosed children and adolescents; full data simultaneously published in The NEJM
TZIELD® Phase 3 data presented at ISPAD shows potential to slow the progression of Stage 3 type 1 diabetes in newly diagnosed children and adolescents; full data simultaneously published in The New England
Source: benzinga.com